Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years.
Fernandez G, Prastawa M, Madduri AS, Scott R, Marami B, Shpalensky N, Cascetta K, Sawyer M, Chan M, Koll G, Shtabsky A, Feliz A, Hansen T, Veremis B, Cordon-Cardo C, Zeineh J, Donovan MJ.
Fernandez G, et al. Among authors: hansen t.
Breast Cancer Res. 2022 Dec 20;24(1):93. doi: 10.1186/s13058-022-01592-2.
Breast Cancer Res. 2022.
PMID: 36539895
Free PMC article.